PATENT CLAIM ANALYSIS

Application Number: 15772550
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-03
Patent Classification: ["514", "052000"]

Abstract:
Provided herein are compounds of Formula (I): or a pharmaceutically acceptable salt thereof, and compositions comprising such compounds that are useful for increasing the amount of NAD+ in cells. Also disclosed are methods of using the disclosed compounds and compositions for treating mitochondrial-related diseases or disorders.

Claim (Index 6):
The compound of  claim 1 , wherein one of R 3a  or R 3b  is hydrogen.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 93.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15766455', '15517893', '14776683', '13837872', '14776688']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7833688375884873
- 35 USC 102 Novelty (BERT): 0.5387688861767292
- Combined Prediction Score: 0.7589088424473115
- Mean Citation Score: 299.075464
- Max Citation Score: 377.4746
- Similarity Product: 312.68516011624337

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test